A critical advance in cancer study is occurring with the use of nanobodies to re-engage damaged p53. This essential tumor inhibitor protein is frequently inactivated in many types of tumors, leading uncontrolled body https://bookmarkusers.com/story21740299/mini-antibodies-revive-tumor-suppressor-p53-new-promising-approach-for-malignant-therapy